Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT05237284 · TERMINATED

Trial details

NCT number: NCT05237284
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-04-13
Primary completion: 2024-03-07
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.